nitroflurbiprofen has been researched along with 4-(3-butoxy-4-methoxybenzyl)-2-imidazolidinone in 1 studies
Studies (nitroflurbiprofen) | Trials (nitroflurbiprofen) | Recent Studies (post-2010) (nitroflurbiprofen) | Studies (4-(3-butoxy-4-methoxybenzyl)-2-imidazolidinone) | Trials (4-(3-butoxy-4-methoxybenzyl)-2-imidazolidinone) | Recent Studies (post-2010) (4-(3-butoxy-4-methoxybenzyl)-2-imidazolidinone) |
---|---|---|---|---|---|
58 | 1 | 6 | 449 | 1 | 24 |
Protein | Taxonomy | nitroflurbiprofen (IC50) | 4-(3-butoxy-4-methoxybenzyl)-2-imidazolidinone (IC50) |
---|---|---|---|
cAMP-specific 3',5'-cyclic phosphodiesterase 4D | Rattus norvegicus (Norway rat) | 6 | |
cAMP-specific 3',5'-cyclic phosphodiesterase 4C | Rattus norvegicus (Norway rat) | 6 | |
cAMP-specific 3',5'-cyclic phosphodiesterase 4B | Rattus norvegicus (Norway rat) | 6 | |
cAMP-specific 3',5'-cyclic phosphodiesterase 4A | Homo sapiens (human) | 4.55 | |
cAMP-specific 3',5'-cyclic phosphodiesterase 4A | Rattus norvegicus (Norway rat) | 6 | |
cAMP-specific 3',5'-cyclic phosphodiesterase 4B | Homo sapiens (human) | 4.8 | |
cAMP-specific 3',5'-cyclic phosphodiesterase 4C | Homo sapiens (human) | 4.8 | |
cAMP-specific 3',5'-cyclic phosphodiesterase 4D | Homo sapiens (human) | 4.8 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Breese, E; Del Soldato, P; Mitchell, J; Warner, T; Wood, E; Zacharowski, P | 1 |
1 other study(ies) available for nitroflurbiprofen and 4-(3-butoxy-4-methoxybenzyl)-2-imidazolidinone
Article | Year |
---|---|
NSAIDs increase GM-CSF release by human synoviocytes: comparison with nitric oxide-donating derivatives.
Topics: 1-Methyl-3-isobutylxanthine; 4-(3-Butoxy-4-methoxybenzyl)-2-imidazolidinone; Anti-Inflammatory Agents, Non-Steroidal; Aspirin; Blotting, Western; Cells, Cultured; Cyclic AMP; Cyclic GMP; Cyclooxygenase 2; Cyclooxygenase 2 Inhibitors; Cyclooxygenase Inhibitors; Dinoprostone; Dose-Response Relationship, Drug; Flurbiprofen; Granulocyte-Macrophage Colony-Stimulating Factor; Humans; Indomethacin; Membrane Proteins; Naproxen; Nitric Oxide Donors; Nitroprusside; Phosphodiesterase Inhibitors; Prostaglandin-Endoperoxide Synthases; Purinones; Synovial Membrane; Time Factors | 2005 |